CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 985812-985976 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T92805","span":{"begin":0,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T265","span":{"begin":0,"end":164},"obj":"Sentence"}],"text":"The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3029","span":{"begin":34,"end":37},"obj":"Body_part"}],"attributes":[{"id":"A3029","pred":"uberon_id","subj":"T3029","obj":"http://purl.obolibrary.org/obo/UBERON_0001359"}],"text":"The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6105","span":{"begin":152,"end":154},"obj":"Disease"},{"id":"T80287","span":{"begin":152,"end":154},"obj":"Disease"}],"attributes":[{"id":"A6105","pred":"mondo_id","subj":"T6105","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A33190","pred":"mondo_id","subj":"T80287","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"The effect(s) of Rituximab on the CSF B cell compartment are limited in comparison to the periphery, but will need to be confirmed in a larger group of MS patients."}